Company Profile: Range Biotechnologies
Overview
Range Biotechnologies is a leading player in the field of translational proteomics, based in San Carlos, California at 733 Industrial Rd. The company is dedicated to advancing human health through innovating in proteomics, the large-scale study of proteins. Their efforts are concentrated on developing tools for personalized health, aiming to improve diagnostics and accelerate drug development processes.
Key Executives
- Dr. Brandon Wilson: Co-Founder & CEO of Range Biotechnologies. Dr. Wilson has a strong background in biomedical sciences, having obtained his Ph.D. from Stanford University. Prior to Range Biotechnologies, he co-founded Verre Vert, which focuses on technological advancements.
- Dr. Nicolò (Nico) Maganzini: Co-Founder & Chief Technology Officer. Also a Stanford University alum, Dr. Maganzini collaborates closely with Dr. Wilson in developing the company's core technologies, leveraging their shared experience from working together as lab mates.
Strategic Initiatives and Funding
Range Biotechnologies recently raised $5.2 million in seed funding, announced on June 12, 2023. The round was led by prominent investors such as ARTIS Ventures, Civilization Ventures, Four Cities Capital, Hawktail, Pear VC, Pillar, and Page One Ventures. This financial boost will aid the company in pioneering personalized health solutions through its expertise in translational proteomics.
Product and Research Focus
The company's primary focus is on the scalable and targeted quantification of protein biomarkers. With innovative approaches, Range Biotechnologies aims to overcome the current limitations in proteomics, enhancing biomarker discovery through effective quantification methods.
Industry Position and Public Engagements
Operating within the biotechnology research sector, Range Biotechnologies employs a small, agile team of 9 professionals. Their work in translational proteomics is crucial for the future of human health advancements, marking them as an influential entity in the industry.
The company disseminates updates and insights through its website, and actively engages with industry circles via interviews with platforms like Longevity.Technology and Pulse 2.0, demonstrating their commitment to transparency and collaboration.
Competitor Profile
Key Competitors
Range Biotechnologies operates in a competitive landscape with several notable companies:
1. DiaCarta Inc. - Based in Pleasanton, California, with a focus on precision diagnostics for cancer patient management. The company has an approximate revenue of $30 million and holds regulatory certifications like CLIA and CAP.
2. Mission Bio - Located in South San Francisco, California, specializing in a precision genomics platform for single-cell targeted DNA sequencing. Their technology integrates single-cell techniques to advance precision medicine.
3. Quadrants Scientific - Operating from San Diego, California, providing chemical, microbiological testing, and environmental monitoring services, supporting FDA-regulated industries.
4. Enveda Biosciences - Situated in Boulder, Colorado, they are at the forefront of plant-powered drug discovery using AI and natural samples. They focus on therapeutic areas like inflammation and fibrosis.
5. Atomwise - San Francisco-based, focusing on AI-driven small molecule drug discovery. Atomwise employs deep learning algorithms to optimize the discovery of new therapeutic chemical entities.
Strategic Insights
The biotechnology field, with its focus on precision diagnostics and AI-based drug discovery, presents significant opportunities and competition. Companies like DiaCarta and Atomwise lead with advanced technologies and substantial revenues. As a small yet innovative player, Range Biotechnologies might consider strategic partnerships, technology enhancements, or exploring adjacent markets to fortify its market position. Emphasizing their niche in translational proteomics will be pivotal for differentiation and sustainable growth in this evolving sector.
